One study [93] showed that the prevalence of CD among patients with T2DM with poor glycemic control despite insulin therapy is slightly higher than the actual CD prevalence in the general population, underlying the necessity in this category of patients for further investigations. The gene discussed is INS; the disease is type 2 diabetes mellitus.